Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Minyuan Chen, Puhong Zhang, Yang Zhao, Nadila Duolikun & Linong Ji. (2022) Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China. Diabetes, Metabolic Syndrome and Obesity 15, pages 3375-3385.
Read now
Read now
Theresa L. Garnero, Nichola J. Davis, Magaly Perez-Nieves, Irene Hadjiyianni, Dachuang Cao, Jasmina I. Ivanova & Mark Peyrot. (2018) Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy. Postgraduate Medicine 130:4, pages 394-401.
Read now
Read now
Mark Peyrot, Magaly Perez-Nieves, Jasmina Ivanova, Dachuang Cao, Luke Schmerold, Samaneh Kalirai & Irene Hadjiyianni. (2017) Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational survey. Current Medical Research and Opinion 33:10, pages 1843-1851.
Read now
Read now
Magaly Perez-Nieves, Jasmina I. Ivanova, Irene Hadjiyianni, Chen Zhao, Dachuang Cao, Luke Schmerold, Samaneh Kalirai, Sarah King, Amy M. DeLozier, Howard G. Birnbaum & Mark Peyrot. (2017) Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey. Current Medical Research and Opinion 33:10, pages 1833-1842.
Read now
Read now
Molly G Minze & Lisa M Chastain. (2016) Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide. Therapeutics and Clinical Risk Management 12, pages 471-478.
Read now
Read now
Dilek Gogas Yavuz, Habip Bilen, Seda Sancak, Tayfun Garip, Zeliha Hekimsoy, Ibrahim Sahin, Murat Yilmaz, Hasan Aydin, Aysegul Atmaca, Murat Sert, Pinar Karakaya, Dilek Arpaci, Aytekin Oguz & Nilgun Guvener. (2016) Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Preference and Adherence 10, pages 851-861.
Read now
Read now
Konstantinos Tziomalos. (2016) Adherence to antihyperglycemic treatment: a work in progress. Expert Opinion on Pharmacotherapy 17:12, pages 1579-1580.
Read now
Read now
Articles from other publishers (36)
Aseel Awad Alsaidan, Omar Awad Alsaidan, Tauqeer Hussain Mallhi, Yusra Habib Khan, Abdulaziz Ibrahim Alzarea & Abdullah Salah Alanazi. (2023) Assessment of Adherence to Insulin Injections among Diabetic Patients on Basal-Bolus Regimen in Primary and Secondary Healthcare Centers in Al-Jouf Region of Saudi Arabia; A Descriptive Analysis. Journal of Clinical Medicine 12:10, pages 3474.
Crossref
Crossref
Bruno Guerci. (2023) Quelle place de la diabétologie connectée pour les patients en multi-injections d'insuline ?. Médecine des Maladies Métaboliques 17:2, pages 2S11-2S21.
Crossref
Crossref
Jaein Seo, Sebastian Heidenreich, Esraa Aldalooj, Jiat Ling Poon, Erik Spaepen, Elizabeth L. Eby & Rachel S. Newson. (2022) Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes. The Patient - Patient-Centered Outcomes Research 16:2, pages 127-138.
Crossref
Crossref
Agostino Consoli & Gloria Formoso. (2023) Patient perceptions of insulin therapy in diabetes self-management with insulin injection devices. Acta Diabetologica 60:5, pages 705-710.
Crossref
Crossref
Devin Steenkamp, Elizabeth L Eby, Nany Gulati & Birong Liao. (2021) Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem. Journal of Diabetes Science and Technology 16:4, pages 995-1002.
Crossref
Crossref
Ying Peng, Peihong Xu, Juan Shi, Yifei Zhang, Shujie Wang, Qidong Zheng, Yufan Wang, Tingyu Ke, Li Li, Dong Zhao, Yuancheng Dai, Qijuan Dong, Bangqun Ji, Fengmei Xu, Weiqiong Gu & Weiqing Wang. (2022) Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real‐world data. Journal of Diabetes 14:2, pages 134-143.
Crossref
Crossref
Julio Rosenstock & Stefano Del Prato. (2022) Basal weekly insulins: the way of the future!. Metabolism 126, pages 154924.
Crossref
Crossref
Hiroyuki Ito, Rie Araki, Suzuko Matsumoto, Takuma Izutsu, Eiji Kusano, Jiro Kondo, Hideyuki Inoue, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori & Michiko Togane. (2021) Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control. Diabetology International 13:1, pages 91-100.
Crossref
Crossref
Karen McGuigan, Alyson Hill, Deirdre McCay, Maurice O’Kane & Vivien Coates. (2021) Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework. Frontiers in Clinical Diabetes and Healthcare 2.
Crossref
Crossref
Jianmin Wu, Fritha Morrison, Zhenxiang Zhao, Ginger Haynes, Xuanyao He, Ayad K. Ali, Maria Shubina, Shervin Malmasi, Wendong Ge, Xiaomei Peng & Alexander Turchin. (2021) Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study. Clinical Diabetes and Endocrinology 7:1.
Crossref
Crossref
Susan RobinsonRachel S. Newson, Birong LiaoTessa Kennedy-MartinTadej Battelino. (2021) Missed and Mistimed Insulin Doses in People with Diabetes: A Systematic Literature Review. Diabetes Technology & Therapeutics 23:12, pages 844-856.
Crossref
Crossref
Supratik Bhattacharyya, Aditya Bikram Mishra & Maneesha Khalse. (2021) CLINICAL EFFECTIVENESS OF FIXED DOSE COMBINATION OF EMPAGLIFLOZIN AND LINAGLIPTIN (EMPA/LINA) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS UNWILLING TO CONTINUE BASAL INSULIN THERAPY: A REAL-WORLD EXPERIENCE IN INDIAN SETTING. INDIAN JOURNAL OF APPLIED RESEARCH, pages 42-44.
Crossref
Crossref
Lisa T. Meade & Dawn Battise. (2021) Evaluation of Clinical Outcomes With the V-Go Wearable Insulin Delivery Device in Patients With Type 2 Diabetes. Clinical Diabetes 39:3, pages 297-303.
Crossref
Crossref
Alexander Abitbol, Rick Siemens, Natalie Nightingale, John Stewart, Marie-Josée Toutounji & Ronald Goldenberg. (2021) Persistence of GLP-1 RA in combination with basal insulin among adults with type 2 diabetes in Canada. Diabetes Research and Clinical Practice 177, pages 108920.
Crossref
Crossref
Frank J. Snoek, Lawrence Fisher, William H. Polonsky, Heather Stuckey, Danielle Hessler, Tricia Tang, Norbert Hermanns, Xavier Mundet, Maria Silva, Jackie Sturt, Kentaro Okazaki, Irene Hadjiyianni, Urvi Desai & Magaly Perez-Nieves. (2021) Overcoming psychological insulin resistance: A practical guide for healthcare professionals. Primary Care Diabetes 15:3, pages 619-621.
Crossref
Crossref
William Polonsky, Cory Gamble, Neeraj Iyer, Mona Martin & Carol Hamersky. (2021) Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study. Diabetes Spectrum 34:2, pages 175-183.
Crossref
Crossref
Tevfik Demir, Serap Turan, Kursad Unluhizarci, Oya Topaloglu, Tufan Tukek & Dilek Gogas Yavuz. (2021) Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns. Frontiers in Endocrinology 12.
Crossref
Crossref
Tinna B. Aradóttir, Henrik Bengtsson, Morten L. Jensen, Niels K. Poulsen, Dimitri Boiroux, Lea L. Jensen, Signe Schmidt & Kirsten Nørgaard. (2020) Feasibility of a New Approach to Initiate Insulin in Type 2 Diabetes. Journal of Diabetes Science and Technology 15:2, pages 339-345.
Crossref
Crossref
Fu‐Shun Yen, James Cheng‐Chung Wei, Jia‐Sin Liu, Chih‐Cheng Hsu & Chii‐Min Hwu. (2020) Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study. Journal of Diabetes Investigation 12:2, pages 146-154.
Crossref
Crossref
Daniel N. Thyde, Ali Mohebbi, Henrik Bengtsson, Morten Lind Jensen & Morten Mørup. (2020) Machine Learning-Based Adherence Detection of Type 2 Diabetes Patients on Once-Daily Basal Insulin Injections. Journal of Diabetes Science and Technology 15:1, pages 98-108.
Crossref
Crossref
Duygu Kes & Feray Gökdoğan. (2020) Relationship between medication adherence and psychosocial adjustment in patients with type 2 diabetes: A cross-sectional study. Nordic Journal of Nursing Research 40:3, pages 116-122.
Crossref
Crossref
Fu-Shun Yen, James Cheng-Chung Wei, Jia-Sin Liu, Chih-Cheng Hsu & Chii-Min Hwu. (2020) The factors associated with insulin nonpersistence in persons with type 2 diabetes. Diabetes Research and Clinical Practice 167, pages 108356.
Crossref
Crossref
Semih KALYON, Perihan ÖZKAN GÜMÜŞKAYA, Neslihan ÖZSOY, Mustafa ÖZCAN, Ayşe PALA, Ayşe BASMAKÇI, Yücel ARMAN & Tufan TÜKEK. (2020) Delay in starting insulin therapy in patients with type 2 Diabetes Mellitus. Journal of Surgery and Medicine 4:8, pages 685-688.
Crossref
Crossref
Melissa Scollan-Koliopoulos. (2020) The Multigenerational Legacy of Diabetes, Emotional Reactions, and Insulin Adherence. Journal of Social Health and Diabetes 8:01, pages 018-024.
Crossref
Crossref
Puhong Zhang, Heng Zhang, Xian Li, Minyuan Chen, Du Wang & Linong Ji. (2020) Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus. Endocrinology, Diabetes & Metabolism 3:2.
Crossref
Crossref
Gilmara Holanda da Cunha, Marina Soares Monteiro Fontenele, Larissa Rodrigues Siqueira, Maria Amanda Correia Lima, Maria Elisa Curado Gomes & Ane Kelly Lima Ramalho. (2020) Prática insulinoterápica realizada por pessoas com diabetes na Atenção Primária em Saúde. Revista da Escola de Enfermagem da USP 54.
Crossref
Crossref
S. Khalfa, S. Abrouk, A. Serouti & K. Osmani. (2019) Adhérence et persistance à l’insuline basale chez les patients diabétiques de type 2 non contrôlés par les antidiabétiques oraux, naïfs à l’insuline, en pratique médicale courante en Algérie (étude ADHERE). Médecine des Maladies Métaboliques 13:8, pages 742-748.
Crossref
Crossref
Beverly Everitt, H. Courtenay HarrisonJr.Jr., Carla Nikkel, Emily Laswell & Aleda M.H. Chen. (2019) Clinical and economic considerations based on persistency with a novel insulin delivery device versus conventional insulin delivery in patients with type 2 diabetes: A retrospective analysis. Research in Social and Administrative Pharmacy 15:9, pages 1126-1132.
Crossref
Crossref
Carol M. Hamersky, Moshe Fridman, Cory L. Gamble & Neeraj N. Iyer. (2019) Injectable Antihyperglycemics: A Systematic Review and Critical Analysis of the Literature on Adherence, Persistence, and Health Outcomes. Diabetes Therapy 10:3, pages 865-890.
Crossref
Crossref
Iskandar Idris, Kunal Gulati, Magaly Perez-Nieves, Irene Hadjiyianni, Dachuang Cao, Arash Tahbaz, Jasmina Ivanova & Syed Wasi Hassan. (2019) Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample. Primary Care Diabetes 13:2, pages 106-112.
Crossref
Crossref
Bruno Guerci, Neha Chanan, Simarjeet Kaur, Juan Guillermo Jasso-Mosqueda & Elisheva Lew. (2019) Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes. Diabetes Therapy 10:2, pages 437-449.
Crossref
Crossref
Sabrina Sepúlveda-Rivas, Hans Fritz, Camila Valenzuela, Carlos Santiviago & Javier Morales. (2019) Development of Novel EE/Alginate Polyelectrolyte Complex Nanoparticles for Lysozyme Delivery: Physicochemical Properties and In Vitro Safety. Pharmaceutics 11:3, pages 103.
Crossref
Crossref
Miguel Montenegro-Nicolini, Patricio E. Reyes, Miguel O. Jara, Parameswara R. Vuddanda, Andrónico Neira-Carrillo, Nicole Butto, Sitaram Velaga & Javier O. Morales. (2018) The Effect of Inkjet Printing over Polymeric Films as Potential Buccal Biologics Delivery Systems. AAPS PharmSciTech 19:8, pages 3376-3387.
Crossref
Crossref
S. Halimi. (2018) Diabète de type 2 : observance thérapeutique aux nouveaux antidiabétiques. Médecine des Maladies Métaboliques 12:6, pages 487-495.
Crossref
Crossref
Grigory Sidorenkov, Job F. M. van Boven, Trynke Hoekstra, Giel Nijpels, Klaas Hoogenberg & Petra Denig. (2018) HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups. Diabetes, Obesity and Metabolism 20:8, pages 1957-1964.
Crossref
Crossref
Cynthia HarrisThomas ForstTim HeiseLeona Plum-MörschelElaine WatkinsQianyi ZhangLudi FanParag GarhyanNiels Porksen. (2017) Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8. Diabetes Technology & Therapeutics 19:8, pages 463-470.
Crossref
Crossref